Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001159036-25-000058
Filing Date
2025-11-18
Accepted
2025-11-18 16:50:00
Documents
16
Effectiveness Date
2025-11-18

Document Format Files

Seq Description Document Type Size
1 S-8 s-8elektrofiequityincentiv.htm S-8 88079
2 EX-107 exfilingfees.htm   iXBRL EX-FILING FEES 21650
3 EX-5.1 ex51weilopinion.htm EX-5.1 10236
4 EX-10.1 ex101elektrofiequityincent.htm EX-10.1 131698
5 EX-23.1 ex231-eyconsent.htm EX-23.1 1994
6 GRAPHIC image_0a.jpg GRAPHIC 938
  Complete submission text file 0001159036-25-000058.txt   374156

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4819
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291625 | Film No.: 251495494
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)